Annual Retained Earnings
-$136.04 M
-$60.37 M-79.77%
December 31, 2023
Summary
- As of February 7, 2025, KYTX annual retained earnings is -$136.04 million, with the most recent change of -$60.37 million (-79.77%) on December 31, 2023.
- During the last 3 years, KYTX annual retained earnings has fallen by -$89.26 million (-190.79%).
- KYTX annual retained earnings is now -190.79% below its all-time high of -$46.78 million, reached on December 1, 2021.
Performance
KYTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$226.03 M
-$34.49 M-18.01%
September 30, 2024
Summary
- As of February 7, 2025, KYTX quarterly retained earnings is -$226.03 million, with the most recent change of -$34.49 million (-18.01%) on September 30, 2024.
- Over the past year, KYTX quarterly retained earnings has dropped by -$89.99 million (-66.15%).
- KYTX quarterly retained earnings is now -198.68% below its all-time high of -$75.68 million, reached on December 1, 2022.
Performance
KYTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
KYTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.8% | -66.2% |
| 3 y3 years | -190.8% | -66.2% |
| 5 y5 years | -190.8% | -66.2% |
KYTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -190.8% | at low | -198.7% | at low |
| 5 y | 5-year | -190.8% | at low | -198.7% | at low |
| alltime | all time | -190.8% | at low | -198.7% | at low |
Kyverna Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$226.03 M(+18.0%) |
| Jun 2024 | - | -$191.54 M(+17.7%) |
| Mar 2024 | - | -$162.74 M(+19.6%) |
| Dec 2023 | -$136.04 M | -$136.04 M(+17.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$115.38 M(+52.5%) |
| Dec 2022 | -$75.68 M(+61.8%) | - |
| Dec 2022 | - | -$75.68 M |
| Dec 2021 | -$46.78 M | - |
FAQ
- What is Kyverna Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual retained earnings year-on-year change?
- What is Kyverna Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly retained earnings year-on-year change?
What is Kyverna Therapeutics annual retained earnings?
The current annual retained earnings of KYTX is -$136.04 M
What is the all time high annual retained earnings for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual retained earnings is -$46.78 M
What is Kyverna Therapeutics annual retained earnings year-on-year change?
Over the past year, KYTX annual retained earnings has changed by -$60.37 M (-79.77%)
What is Kyverna Therapeutics quarterly retained earnings?
The current quarterly retained earnings of KYTX is -$226.03 M
What is the all time high quarterly retained earnings for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly retained earnings is -$75.68 M
What is Kyverna Therapeutics quarterly retained earnings year-on-year change?
Over the past year, KYTX quarterly retained earnings has changed by -$89.99 M (-66.15%)